Oscar Health, Inc. Financials

Market Capitalization $4.23 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	41.55
Forward PE	29.68
Price to Sales TTM	$0.42
Price to Book MRQ	$3.16
Enterprise to Revenue	0.28
Enterprise to EBITDA	14.15

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	1.22%
Operating Margin	9.75%
Return on Assets TTM	2.06%
Return on Equity TTM	10.48%

Income Statement

Revenue TTM	$10,081,521,664
Revenue per Share TTM	$41.09
Quarterly Revenue Growth	42.20%
Gross Profit TTM	$2,044,056,064
EBITDA	$199,894,000
Net Income to Common TTM	$123,335,000
Diluted EPS TTM	$0.40
Quarterly Earnings Growth YoY	55.20%

Balance Sheet

Total Cash MRQ	$2,988,044,032
Total Cash per Share MRQ	$11.75
Total Debt MRQ	$
Total Debt to Equity MRQ	26.88
Current Ratio MRQ	0.91
Book Value per Share MRQ	$5.27

Cash Flow

Operating Cash Flow TTM	$1,222,371,968
Levered Free Cash Flow TTM	$1,064,549,504

OSCR Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	250,488,201
Float Shares	206,414,763
Avg 10 Volume	34,958,780
Avg 30 Volume	None
Shares Short	29,748,645
Short Ratio	2.75
Short % of Shares	15.12%
% Held by Insiders	4.13%
% Held by Institutions	86.78%

Stock Price Summary

Beta	1.73
Fifty Two Week Low	$11.20
Fifty Two Week High	$23.79
Fifty Two Week Change	-1.88%
Day 50 MA	$15.67
Day 200 MA	$15.71

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date